Rhumbline Advisers Sesen Bio, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.38 - $0.89 $56,848 - $133,144
-149,600 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$0.58 - $0.86 $6,131 - $9,091
10,572 Added 7.6%
149,600 $90,000
Q4 2021

Feb 10, 2022
SELL
$0.73 - $1.28 $2,496 - $4,377
-3,420 Reduced 2.4%
139,028 $113,000
Q3 2021

Nov 12, 2021
BUY
$0.77 - $4.91 $10,706 - $68,273
13,905 Added 10.82%
142,448 $113,000
Q2 2021

Aug 05, 2021
BUY
$2.18 - $4.66 $280,223 - $599,010
128,543 New
128,543 $594,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Sesen Bio, Inc.

SESN Quotes by TradingView
  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email